Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Hoffmann, KM; Furukawa, M; Jensen, RT.
Duodenal neuroendocrine tumors: Classification, functional syndromes, diagnosis and medical treatment.
Best Pract Res Clin Gastroenterol. 2005; 19(5):675-697
Doi: 10.1016/j.bpg.2005.05.009
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Hoffmann Karl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Duodenal neuroendocrine tumors (NETs) comprise 2-3% of all GI endocrine tumors and are increasing in frequency. These include gastrinomas, somatostatinomas, nonfunctional NETs, gangliocytic paragangliomas, and poorly differentiated NE carcinomas. Although, the majority are nonfunctional, these tumors are a frequent cause of Zollinger-Ellison syndrome and can cause other clinical hormonal syndromes (carcinoid, Cushing's, etc.). In this chapter, their epidemiology, clinical aspects, localization, diagnosis and medical treatment are reviewed including the latest advances in each area.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Age Distribution -
-
Aged -
-
Aged, 80 and over -
-
Biopsy, Needle -
-
Carcinoid Tumor - classification
-
Combined Modality Therapy - classification
-
Duodenal Neoplasms - classification
-
Duodenoscopy - methods
-
Female - methods
-
Humans - methods
-
Immunohistochemistry - methods
-
Incidence - methods
-
Male - methods
-
Middle Aged - methods
-
Neoplasm Staging - methods
-
Neuroendocrine Tumors - classification
-
Prognosis - classification
-
Risk Assessment - classification
-
Sex Distribution - classification
-
Somatostatinoma - classification
-
Survival Analysis - classification
-
United States - epidemiology
-
Zollinger-Ellison Syndrome - classification
- Find related publications in this database (Keywords)
-
duodenal carcinoid
-
carcinoid
-
gastrinoma
-
Zollinger-Ellison syndrome
-
somatostatinoma
-
MEN I
-
gangliocytic paraganglioma
-
von Recklinghausen's disease